Prostate Cancer – Current Treatment – Detailed, Expanded Analysis: Treatment Sequencing (US)

KEY BENEFITS AND USES

  • Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.
  • Drill down into physicians’ treatment sequences and understand who to position against or how to defend share.
  • Identify untapped treatment scenarios and key competitors to aid trial design.
  • Evaluate unique disease-specific treatment patterns and dynamics to plan and manage sales and marketing resources and execute commercialization messages.
  • Discover untapped populations to expand product share and drive strategic decisions.

QUESTIONS ANSWERED
• Where is my product positioned vs. competitors in the treatment journey?
• What are physicians’ most frequent treatment sequences—who is
benefiting and how can I defend my assets share and position?
• What are the market-relevant treatment scenarios according to oncology
experts?
• Where are the untapped business opportunities that I can capitalize
upon?
• How can I optimize trial design and ensure a competitive edge for my
pipeline asset?

GEOGRAPHIES
United States
PRIMARY MARKET RESEARCH
Survey of ~100 U.S. physicians
2019 COVERAGE
Colorectal Cancer (US)
Multiple Myeloma (US)
Non-Hodgkin's Lymphoma and
Chronic Lymphocytic Leukemia
(US)
Non-Small-Cell Lung Cancer (US)
Ovarian Cancer (US)
Prostate Cancer (US)
Renal Cell Carcinoma (US)

KEY FEATURES

  • Market-relevant treatment scenarios and subpopulations from oncology experts
  • Drug share and treatment rates mapped to treatment journey using physician survey data
  • Physicians’ most frequently selected treatment sequences
  • Access to expert oncology analysts for bespoke support

PRODUCT DESCRIPTION
Treatment Sequencing provides disease-specific, sequential treatment
patterns in market-relevant treatment scenarios and drug share mapped to
treatment journey. The quantitative sequencing analysis illuminates drug
positioning through primary market research-based insights from physicians
and DRG oncology experts’ assumptions.

Table of contents

  • Prostate Cancer - Current Treatment - Detailed, Expanded Analysis: Treatment Sequencing (US)
    • Treatment Sequencing Prostate Cancer US June 2019

Login to access report

launch Related Market Assessment Reports